TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
Zhejiang University
Zhejiang University
China-Japan Friendship Hospital
University of California, San Francisco
Medtronic - MITG
National Institutes of Health Clinical Center (CC)
Lo.Li.Pharma s.r.l
Virtual Tribunal Monastery
University of California, San Francisco
Cangzhou Central Hospital
Qilu Pharmaceutical Co., Ltd.
Ain Shams University
JW Pharmaceutical
Centro di Ricerca Clinica Salentino
Alexandria University
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Johns Hopkins University
Sumitomo Pharma Switzerland GmbH
University of Miami
University of California, Los Angeles
Yuri Semenyuk Rivne Regional Clinical Hospital
Endeavor Health
Johns Hopkins University
Tongji Hospital
Centro di Ricerca Clinica Salentino
Kissei Pharmaceutical Co., Ltd.
Assistance Publique - Hôpitaux de Paris
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Institut Bergonié
Acessa Health, Inc.
University of Chicago
West China Second University Hospital
AbbVie
Tongji Hospital
University Hospital, Geneva
Zenchi, Inc.
Terumo Medical Corporation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Centre Hospitalier Intercommunal Creteil
Sumitomo Pharma Switzerland GmbH
Jiangsu HengRui Medicine Co., Ltd.
Tongji Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sumitomo Pharma Switzerland GmbH
University Hospitals Cleveland Medical Center
The University of Texas Medical Branch, Galveston
Sumitomo Pharma Switzerland GmbH
Washington University School of Medicine
University of Faisalabad
Bayer
Yale University